Beta Bionics outlines $130M–$135M 2026 revenue target while expanding sales force and pharmacy channel

Q4 2025 earnings call recap: revenue growth, 2026 guidance, gross margin outlook, pharmacy mix, FDA update & risks—read now.
Nasdaq

Beta Bionics, Inc. to Release First Quarter 2025 Financial Results on May 6, 2025

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...
Morningstar

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

Net sales of $17.6 million, up 36% compared to $12.9 million in the first quarter of 2024. Durable Medical Equipment (DME) channel net sales of $13.8 million, up 14% compared to $12.1 million in the ...

Beta Bionics, Inc. (NASDAQ:BBNX) Q4 2025 earnings call transcript

Beta Bionics, Inc. (NASDAQ:BBNX) Q4 2025 Earnings Call Transcript February 18, 2026 Operator: Good day, and thank you for standing by. Welcome to the Beta Bionics Inc. Q4 and Full Year 2025 Earnings ...
The Grand Junction Daily Sentinel

World’s first waterproof bionic arm submerged in water tank

An amazing video shows the world’s first fully waterproof bionic arm submerged in a water tank. Open Bionics, based in Bristol, UK, launched its state-of-the-art Hero RGD and Hero PRO bionic hands on ...